SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for s ...
On the upside, the Nifty 50 may face resistance at 23,850, followed by 24,000, which is a key resistance level. On the downside, 23,700 is expected to be immediate support, followed by 23,550 (near ...
In 2021, the United States faced a significant industry-wide shortage of infant formula due to COVID-19-related supply challenges which was exacerbated by a massive formula recall involving one of the ...